Kendall Preston

Kendall Preston, Ph.D., is a Senior Scientist at AstraZeneca, specializing in early stage formulation sciences. With a background in chemical and biological engineering, Kendall has significant research experience in protein and vaccine formulation, lyophilization, and characterization, utilizing various biophysical analytical methods. Previously, Kendall held positions as a Scientist at GSK and a Graduate Research Assistant at the University of Colorado Boulder, where they developed a trivalent filovirus adjuvanted subunit vaccine. Kendall's career began as an Undergraduate Research Assistant at Iowa State University and further included a Research and Development Co-op at Encapsys.